Ownership history in UBS Group AG · 8 quarters on record
This page tracks every 13F SEC filing in which UBS Group AG reported a position in BIOAFFINITY TECHNOLOGIES INC (BIAF). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 143 | +119 | +495.8% | 0.00% | $423 | $2.96 |
| 2025 Q2 | REDUCED | 24 | -9,567 | -99.7% | 0.00% | $7 | $8.61 |
| 2024 Q2 | ADDED | 9,591 | +9,526 | +14655.4% | 0.00% | $21K | $64.80 |
| 2023 Q3 | REDUCED | 65 | -30 | -31.6% | 0.00% | $76 | $34.92 |
| 2023 Q2 | REDUCED | 95 | -2,314 | -96.1% | 0.00% | $174 | $54.90 |
| 2023 Q1 | REDUCED | 2,409 | -4,172 | -63.4% | 0.00% | $5K | $56.70 |
| 2022 Q4 | ADDED | 6,581 | +1,658 | +33.7% | 0.00% | $11K | $48.00 |
| 2022 Q3 | INITIATED | 4,923 | — | — | 0.00% | $14K | $87.30 |
As of 2025 Q4 — sorted by position size